| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802405301014 | 240530101 | CERAZETTE F.C.TAB 0,075MG/TAB BTx28 (BLIST 1x28) | 3.12 | 3.29 | 4.71 |
For the prevention of pregnancy in women who elect to use this product as a method of contraception.
Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like desogestrel will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge.
Symptoms of overdose include nausea and vaginal bleeding.
Following oral administration, the relative bioavailability of desogestrel compared to a solution, as measured by serum levels of etonogestrel, is approximately 100%.
27.8±7.2 hours